Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) caters to the Technology space. It has a net profit margin of -10.00% and weekly performance is -19.30%. On the last day of trading company shares ended up at $0.46. Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) distance from 50-day simple moving average (SMA50) is -42.94%.
Yingli Green Energy Holding Company Limited is a supplier of vertically integrated photovoltaic (PV) module. The Company’s products and services cover the entire PV industry value chain, ranging from crystalline polysilicon ingots and wafers, PV cells and PV modules to the manufacture of PV systems and the installation of PV systems.
Yingli Green Energy Holding Co Ltd (ADR) (NYSE:YGE), announced that its holding subsidiary, Yingli Energy (Beijing) Company Limited has entered into an agreement with CFC Group Construction Limited(“CFC Construction”) to supply 170 megawatts (MW) of solar panels for utility-scale power plants in China’s Hebei province. It is Yingli’s largest solar panel supply agreement to date in China.
Tangoe, Inc. (NASDAQ:TNGO) ended the last trading day at $7.74. Company weekly volatility is calculated as 2.60% and price to cash ratio as 8.35. Tangoe, Inc. (NASDAQ:TNGO) showed a weekly performance of -1.53%.
Tangoe, Inc. (Tangoe) is a global provider of connection lifecycle management (CLM), software and services to a range of enterprises and service providers. CLM covers the entire spectrum of an enterprise’s connection-based assets and services, such as voice and data services, mobile devices and usage, cloud software, infrastructure and services, machine-to-machine connections, enterprise social and information technology connections.
Tangoe, Inc. (NASDAQ: TNGO), announced that it has enhanced the audit capabilities across all of the Matrix solution lines including Fixed, Mobile, Cloud, IT, Machine and Internet of Things (IoT). With Tangoe’s Matrix solutions, auditors are able to view all claims and audits within one centralized application designed to automate the entire process, creating a one-stop shop for all IT expense needs regardless of connection type.
On 22 September, Lululemon Athletica Inc. (NASDAQ:LULU) shares advanced 1.37% and was closed at $54.72. LULU EPS growth in last 5 year was 32.30%. Lululemon Athletica Inc. (NASDAQ:LULU) year to date (YTD) performance is -1.92%.
lululemon athletica inc. is a designer and retailer of technical athletic apparel. The Company offers a line of apparel and accessories for women, men and female youth. Its apparel assortment includes items, such as pants, shorts, tops and jackets designed for healthy lifestyle activities and athletic pursuits, such as yoga, running, general fitness and dance-inspired apparel for female youth.
Lululemon Athletica inc. (NASDAQ:LULU) has been facing stiff competition from the likes of Nike and Addidas. Even though the company commands a significant share of the market, it has recently been losing a lot of its customers. However, the new management, under the helm of CEO, Laurent Potdevin, has been making efforts to recapture the market, with some success.
GTX Inc. (NASDAQ:GTXI) shares moved down -9.17% in last trading session and ended the day at $0.99. Its has a return on assets of -184.40%. GTX Inc. (NASDAQ:GTXI) quarterly performance is -33.56%.
GTX Inc. (NASDAQ:GTXI) provides an overview of the GTx, Inc.’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for GTx, Inc., complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Agile Therapeutics, Inc. (NASDAQ:AGRX) caters to the Healthcare space. Its weekly performance is 2.77%. On the last day of trading company shares ended up at $8.16. Agile Therapeutics, Inc. (NASDAQ:AGRX) distance from 50-day simple moving average (SMA50) is -9.52%.
Agile Therapeutics, Inc. is a women’s health specialty pharmaceutical company. The Company is engaged in the development and commercialization of prescription contraceptive products. The Company’s product candidates are designed to provide women with contraceptive options. The Company has developed a transdermal patch technology, called Skinfusion. The Company’s lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch in Phase III clinical development.
On Aug. 31, 2015 Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced that active recruitment has closed in its ongoing single-arm, open-label Phase 3 SECURE clinical trial of Twirla® (AG200-15), its investigational contraceptive patch. Participating sites will complete screening over the next two weeks, and the Company expects to complete enrollment by the end of the third quarter 2015.
Leave a Reply